title: New oral anticoagulants in non-valvular atrial fibrillation.
abstract: Atrial fibrillation (AF) is associated with an increased risk of embolic stroke. Dose-adjusted vitamin K antagonists (VKAs) to a target international normalized ratio (INR) range of 2.0-3.0 reduce the risk of ischemic stroke and are currently recommended in all patients with AF at moderate-high risk for stroke or systemic embolism. However, VKAs have several drawbacks, including unpredictable anticoagulant response, food and drug interactions, need for regular laboratory monitoring and dose adjustment. These limitations prompted the introduction of new oral anticoagulants (NOA) that target thrombin and factor Xa, key-enzymes in the coagulation pathway. NOA have predictable pharmacodynamics, allowing fixed dosing without the need of laboratory monitoring, and have few drug and food interactions. The present review focuses on pharmacological properties, safety, and appropriate clinical use of dabigatran, rivaroxaban and apixaban.
authors: Division of Cardiology, Department of Clinical and Molecular Medicine, University of Rome Sapienza, Sant'Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy. pietro.francia@uniroma1.it
authors: Pietro
authors: P
authors: Francia
authors: Carmen
authors: C
authors: Adduci
authors: Daria
authors: D
authors: Santini
authors: Beatrice
authors: B
authors: Musumeci
authors: Giuliano
authors: G
authors: Tocci
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects; D016903:Drug Monitoring / Q000379:methods; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D019934:International Normalized Ratio; D020521:Stroke / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants
references: Thromb Haemost. 2012 Feb;107(2):379-87
references: 22187012
references: Circulation. 2010 Apr 6;121(13):1523-32
references: 20368532
references: Thromb Res. 2011 Jan;127 Suppl 2:S5-S12
references: 21193114
references: J Med Toxicol. 2011 Dec;7(4):281-7
references: 21887485
references: J Thromb Haemost. 2010 Apr;8(4):621-6
references: 20102486
references: Drug Metab Dispos. 2008 Feb;36(2):386-99
references: 18006647
references: J Thromb Haemost. 2011 Sep;9(9):1705-12
references: 21729240
references: N Engl J Med. 2011 Sep 15;365(11):981-92
references: 21870978
references: Thromb Haemost. 2010 Jul;104(1):49-60
references: 20539909
references: Thromb Haemost. 2010 Jan;103(1):62-70
references: 20062934
references: Eur Heart J. 2010 Oct;31(19):2369-429
references: 20802247
references: Vasc Health Risk Manag. 2010 May 25;6:339-49
references: 20531953
references: Br J Clin Pharmacol. 2007 Sep;64(3):292-303
references: 17506785
references: BMJ. 2011 Jan 18;342:c7270
references: 21245113
references: Thromb Haemost. 2010 Dec;104(6):1263-71
references: 20978714
references: Circulation. 2011 May 31;123(21):2363-72
references: 21576658
references: Neth J Med. 2011 Jun;69(6):268-73
references: 21868810
references: Circulation. 2011 Oct 4;124(14):1573-9
references: 21900088
references: Thromb Haemost. 2010 Jun;103(6):1116-27
references: 20352166
references: Ann Intern Med. 2007 Jun 19;146(12):857-67
references: 17577005
references: J Thromb Thrombolysis. 2011 May;31(4):478-92
references: 21318583
references: Clin Pharmacokinet. 2010 Apr;49(4):259-68
references: 20214409
references: N Engl J Med. 2011 May 12;364(19):1788-90
references: 21488759
references: Blood. 2010 Jan 7;115(1):15-20
references: 19880491
references: J Cardiovasc Electrophysiol. 2008 May;19(5):457-62
references: 18266680
references: Am J Health Syst Pharm. 2012 Sep 1;69(17):1473-84
references: 22899742
references: Circulation. 2011 Apr 5;123(13):1436-50
references: 21464059
references: Clin Cardiol. 2012 Dec;35(12):730-7
references: 22811404
references: Blood. 2012 Mar 29;119(13):3016-23
references: 22302737
references: Transfus Med Rev. 2007 Jan;21(1):37-48
references: 17174219
references: Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):376-81
references: 20139357
references: Thromb Haemost. 2012 May;107(5):985-97
references: 22438031
references: Eur Heart J. 2012 Nov;33(21):2719-47
references: 22922413
references: Circulation. 2011 Mar 15;123(10):1144-50
references: 21321155
references: Thromb Res. 2012 Feb;129(2):107-15
references: 22014849
references: N Engl J Med. 2011 Sep 8;365(10):883-91
references: 21830957
references: Chest. 2008 Jun;133(6 Suppl):160S-198S
references: 18574265
references: Am J Cardiol. 1998 Oct 16;82(8A):2N-9N
references: 9809895
references: Thromb Haemost. 2011 Apr;105(4):735-6
references: 21225100
references: N Engl J Med. 2009 Sep 17;361(12):1139-51
references: 19717844
references: J Cardiovasc Electrophysiol. 2011 Aug;22(8):948-55
references: 21668558